Blood-Borne Diseases

Quest Diagnostics has just launched a new hepatitis B virus quantitative test that will allow physicians to more effectively monitor patient response to antiviral drugs and tailor treatment regimens.

Insurance companies are denying members coverage to expensive drugs, like Harvoni, and those infected with HCV are filing lawsuits.

A new project aims to develop and assess new hepatitis C vaccination strategies in an effort to improve treatment.

New research from the Medical University of Vienna has made a connect between blood infections and an increased risk of arteriosclerosis.

Researchers have found that multidrug-resistant Candida auris, though capable of forming a biofilm that aids in its spread throughout hospitals, is susceptible to chlorhexidine.

In a phase 3 clinical trial, Japanese patients with chronic hepatitis C (HCV) infection without liver cirrhosis were able to achieve high sustained viral response rates after taking an investigational HCV drug from AbbVie.

Monique Foster, MD, MPH, EIS officer, Division of Viral Hepatitis, Centers for Disease Control and Prevention, explains why it’s important for individuals to know that they are infected with hepatitis C, although they may be asymptomatic.

These findings discredit previous allegations that this outbreak was the cause of one source and that the number of cases is higher than that identified in previous years.

Researchers have found potential evidence that suggests Ebola may be able to replicate in the lungs of recovering patients.

Researchers have found that anemia offers protection against malaria in African children and that iron supplements may actually reverse this protective effect.

Despite the fact that an increasingly large portion of the hepatitis C (HCV)-infected population successfully achieves a cure for the infection, called sustained viral response (SVR), this population still deals with increased mortality rates.

A new coalition created by the Bill & Melinda Gates Foundation and other global partners will launch at this year’s World Economic Forum, with the goal of supporting the fast-tracked development of new vaccines.

Researchers have found that an experimental vaccine designed to fight the Ebola virus has proven to be highly protective.

The European Medicines Agency (EMA) released guidelines recommending screening for hepatitis B in patients who are infected with hepatitis C prior to starting treatment with direct-acting antivirals.

Researchers from Purdue University have discovered a connection between hepatitis B (HBV) infection and liver cancer.

In a new study, a team of pediatric hospital researchers found that cutting unnecessary blood cultures in children avoids false positives without resulting in missed sepsis diagnoses.

Why do more HCV-infected immigrants, rather than non-immigrants, end up hospitalized for liver problems? Inadequate screening and longer infection duration are likely reasons.

In a review article, researchers share current understanding of the pathogenesis of type IV T cell-dependent immune-mediated ADRs and review the evidence for diagnostics for T cell-mediated ADRs.

A defense mechanism by which plants and animals fight off RNA viruses was recently observed in human cells for the first time, offering researchers a look at new ways to treat viral diseases.

In response to the hepatitis C virus outbreak in Kentucky, political and healthcare officials are debating the implementation of a needle exchange program for injection drug users.

Nicholas J. White, MD, shares his “Personal View” on mass drug administration (MDA) as a means of malaria prophylaxis.

A new potential case of the Ebola virus has been reported in Canada.

Studies find that a mutated gene that encodes the Ebola virus glycoprotein increased its ability to infect human and primate cells in the 2013-2106 West African epidemic.

Researchers have not been able to develop a vaccine for hepatitis C, which causes 700,000 deaths around the world annually, and now, a new study shows why developing a vaccine for the virus has been so difficult.

“The number of people who experience the devastating effects of preventable infectious diseases like measles, diphtheria, and whooping cough is at an all-time low," according to the Centers for Disease Control and Prevention (CDC).

The Georgia HCV Elimination Program, the first of its kind, is being heralded as a model for other countries that face a high rate of HCV infection.

An employee in the prepared foods section of a Whole Foods Market in Detroit, Michigan, has been diagnosed with hepatitis A.

A team of researchers at the University of California has found that veterans infected with both hepatitis C and human immunodeficiency virus sought treatment more often than those infected with just one of the viruses.

The National Institutes of Health have granted $3 million to researchers at the University of Missouri Bond Life Sciences Center to study hepatitis B and develop new, effective treatment options.